| Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial J Overgaard, HS Hansen, L Specht, M Overgaard, C Grau, E Andersen, ... The Lancet 362 (9388), 933-940, 2003 | 800 | 2003 |
| MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy S Elad, KKF Cheng, RV Lalla, N Yarom, C Hong, RM Logan, J Bowen, ... Cancer 126 (19), 4423-4431, 2020 | 379 | 2020 |
| Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis B Lacas, J Bourhis, J Overgaard, Q Zhang, V Grégoire, M Nankivell, ... The Lancet Oncology 18 (9), 1221-1237, 2017 | 330 | 2017 |
| FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial LS Mortensen, J Johansen, J Kallehauge, H Primdahl, M Busk, P Lassen, ... Radiotherapy and oncology 105 (1), 14-20, 2012 | 330 | 2012 |
| Delineation of the primary tumour clinical target volumes (ctv-p) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: Airo, caca, dahanca … V Grégoire, M Evans, QT Le, J Bourhis, V Budach, A Chen, A Eisbruch, ... Radiotherapy and Oncology 126 (1), 3-24, 2018 | 316 | 2018 |
| Salivary gland carcinoma in Denmark 1990–2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA) K Bjørndal, A Krogdahl, MH Therkildsen, J Overgaard, J Johansen, ... Oral oncology 47 (7), 677-682, 2011 | 271 | 2011 |
| Single arc volumetric modulated arc therapy of head and neck cancer A Bertelsen, CR Hansen, J Johansen, C Brink Radiotherapy and Oncology 95 (2), 142-148, 2010 | 271 | 2010 |
| The prognostic significance of histological features in oral squamous cell carcinoma SR Larsen, J Johansen, JA Sørensen, A Krogdahl Journal of oral pathology & medicine 38 (8), 657-662, 2009 | 235 | 2009 |
| Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement DJ Thomson, D Palma, M Guckenberger, P Balermpas, JJ Beitler, ... International Journal of Radiation Oncology* Biology* Physics 107 (4), 618-627, 2020 | 229 | 2020 |
| Prospective study of 18FDG‐PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA‐13 study J Johansen, S Buus, A Loft, S Keiding, M Overgaard, HS Hansen, C Grau, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2008 | 212 | 2008 |
| Turning subjective into objective: the BCCT. core software for evaluation of cosmetic results in breast cancer conservative treatment MJ Cardoso, J Cardoso, N Amaral, I Azevedo, L Barreau, M Bernardo, ... The Breast 16 (5), 456-461, 2007 | 208 | 2007 |
| The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial P Lassen, JG Eriksen, A Krogdahl, MH Therkildsen, BP Ulhøi, ... Radiotherapy and Oncology 100 (1), 49-55, 2011 | 207 | 2011 |
| Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy J Johansen, SM Bentzen, J Overgaard, M Overgaard Radiotherapy and oncology 40 (2), 101-109, 1996 | 200 | 1996 |
| Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines CHL Hong, LA Gueiros, JS Fulton, KKF Cheng, A Kandwal, D Galiti, ... Supportive care in cancer 27, 3949-3967, 2019 | 199 | 2019 |
| Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer P Lassen, H Primdahl, J Johansen, CA Kristensen, E Andersen, ... Radiotherapy and Oncology 113 (3), 310-316, 2014 | 188 | 2014 |
| Is there more than one late radiation proctitis syndrome? JW Denham, PC O'Brien, RH Dunstan, J Johansen, A See, CS Hamilton, ... Radiotherapy and Oncology 51 (1), 43-53, 1999 | 183 | 1999 |
| Automatic planning of head and neck treatment plans I Hazell, K Bzdusek, P Kumar, CR Hansen, A Bertelsen, JG Eriksen, ... Journal of applied clinical medical physics 17 (1), 272-282, 2016 | 163 | 2016 |
| Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal … NG Burnet, J Johansen, I Turesson, J Nyman, JH Peacock International journal of cancer 79 (6), 606-613, 1998 | 156 | 1998 |
| Implication of 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study J Johansen, A Eigtved, C Buchwald, SA Theilgaard, HS Hansen The Laryngoscope 112 (11), 2009-2014, 2002 | 145 | 2002 |
| 6LB Randomized study of the importance of Novel Erythropoiesis Stimulating Protein (Aranesp®) for the effect of radiotherapy in patients with primary squamous cell carcinoma of … J Overgaard, C Hoff, HS Hansen, L Specht, M Overgaard, C Grau, ... European Journal of Cancer Supplements 5 (6), 7, 2007 | 142 | 2007 |
